MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/jitc-2019-000251

Медицинская библиотека · Journal for immunotherapy of cancer · 2020

T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma.

Vroman Heleen, Balzaretti Giulia, Belderbos Robert A, Klarenbeek Paul L, van Nimwegen Menno, Bezemer Koen, Cornelissen Robin, Niewold Ilse T G, van Schaik Barbera D, van Kampen Antione H, Aerts Joachim G J V, de Vries Niek, Hendriks Rudi W

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Malignant pleural mesothelioma (MPM) is a highly lethal malignancy in need for new treatment options. Although immunotherapies have been shown to boost a tumor-specific immune response, not all patients respond and prognostic biomarkers are scarce. In this study, we determined the peripheral blood T cell receptor β (TCRβ) chain repertoire of nine MPM patients before and 5 weeks after the start of dendritic cell (DC)-based immunotherapy.

MATERIALS AND

METHODS

We separately profiled PD1+ and PD1-CD4+ and CD8+ T cells, as well as Tregs and analyzed 70 000 TCRβ sequences per patient.

RESULTS

Strikingly, limited TCRβ repertoire diversity and high average clone sizes in total CD3+ T cells before the start of immunotherapy were associated with a better clinical response. To explore the differences in TCRβ repertoire prior-DC-therapy and post-DC-therapy, for each patient the TCRβ clones present in the total CD3+ T cell fractions were classified into five categories, based on therapy-associated frequency changes: expanding, decreasing, stable, newly appearing and disappearing clones. Subsequently, the presence of these five groups of clones was analyzed in the individual sorted T cell fractions. DC-therapy primarily induced TCRβ repertoire changes in the PD1+CD4+ and PD1+CD8+ T cell fractions. In particular, in the PD1+CD8+ T cell subpopulation we found high frequencies of expanding, decreasing and newly appearing clones. Conversion from a PD1- to a PD1+ phenotype was significantly more frequent in CD8+ T cells than in CD4+ T cells. Hereby, the number of expanding PD1+CD8+ T cell clones-and not expanding PD1+CD4+ T cell clones following immunotherapy positively correlated with overall survival, progression-free survival and reduction of tumor volume.

CONCLUSION

We conclude that the clinical response to DC-mediated immunotherapy is dependent on both the pre-existing TCRβ repertoire of total CD3+ T cells and on therapy-induced changes, in particular expanding PD1+CD8+ T cell clones. Therefore, TCRβ repertoire profiling in sorted T cell subsets could serve as predictive biomarker for the selection of MPM patients that benefit from immunotherapy.

TRIAL REGISTRATION NUMBER: NCT02395679.

Для цитирования: Vroman Heleen, Balzaretti Giulia, Belderbos Robert A, Klarenbeek Paul L, van Nimwegen Menno, Bezemer Koen, Cornelissen Robin, Niewold Ilse T G, van Schaik Barbera D, van Kampen Antione H, Aerts Joachim G J V, de Vries Niek, Hendriks Rudi W. T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma.. Journal for immunotherapy of cancer. 2020. DOI: 10.1136/jitc-2019-000251.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.